Down’s syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials
✍ Scribed by Dördelmann, M; Schrappe, M; Reiter, A; Zimmermann, M; Graf, N; Schott, G; Lampert, F; Harbott, J; Niemeyer, C; Ritter, J
- Book ID
- 110053817
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 133 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Of 2947 children with acute lymphocytic leukemia (ALL), treated during three consecutive studies of the Pediatric Oncology Group (1974-1986), 52 (1.8%) had Down's Syndrome (DS). Comparison of clinical and laboratory characteristics showed no significant differences in leukocyte count, racial distrib
## Purpose: To report the feasibility and results of a study based on the bfm-all. nhl/86 protocol for b-non-hodgin's lymphoma (nhl) and b-acute lymphoblastic leukemia (b-all) in argentina. design. prospective, single arm, non-randomized trial. ## Patients and methods: From august 1988 to decembe
Seventy-three consecutive cases of childhood acute lymphoblastic leukemia (ALL) diagnosed and managed in Queen Mary Hospital over a 10-year period from 1985 to 1994 were retrospectively analysed for their presenting features and treatment outcome. The 48 boys and 25 girls ranged in age from 0•4 to 1